Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intravenous Thyroxine for Heart-Eligible Brain Dead Organ Donors
NCT04415658Phase 3Completed
- Sponsor
- Washington University School of Medicine
- Start
- Dec 2020
- Primary completion
- Nov 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of levothyroxine sodium in brain death, sponsored by Washington University School of Medicine. Started Dec 2020; status: completed.
02
Drugs
levothyroxine sodium
03
Conditions
brain death
Beyond the preview
Go deeper on NCT04415658.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04415658.